Vimarsana
Biggest News Aggregation in the World

Page 4 - Redsa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Redsa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Redsa Today - Breaking & Trending Today

MAP backs restrictions on EDSA busway | The Manila Times - Vimarsana News

MAP backs restrictions on EDSA busway | The Manila Times

MANILA, Philippines: The Management Association of the Philippines (MAP) said it supported the restrictions of the Department of Transportation (DoTr) on the access and use of the busways along EDSA.

MMDA official suspended over EDSA bus lane fiasco - Vimarsana News

MMDA official suspended over EDSA bus lane fiasco

MANILA, Philippines: Metropolitan Manila Development Authority (MMDA) Task Force Special Operations Chief Edison 'Bong' Nebrija was suspended starting Thursday to ensure a fair investigation into reports in which he alleged that one of the vehicles that were apprehended along the EDSA Carousel Bus Lane belonged to Sen. Ramon 'Bong' Revilla Jr.

Shouldn't BBM ask JPE about the EDSA revolt? - Vimarsana News

Shouldn't BBM ask JPE about the EDSA revolt?

SOME highly spirited citizens are reported to have sent personal emails to President Ferdinand Marcos Jr. asking him to revoke his decision not to declare the commemoration of the 1986 'EDSA revolution' as a nonworking special holiday for Filipinos.

EDSA Revolution not in 2024 holidays list | The Manila Times - Vimarsana News

EDSA Revolution not in 2024 holidays list | The Manila Times

(UPDATE) PRESIDENT Ferdinand Marcos Jr. declared 20 national holidays for 2024, but the list does not include the observance of the EDSA Revolution that ousted his father in 1986.

Edesa Biotech (NASDAQ:EDSA) Given "Buy" Rating at Brookline Capital Management - Vimarsana News

Edesa Biotech (NASDAQ:EDSA) Given "Buy" Rating at Brookline Capital Management

Edesa Biotech (NASDAQ:EDSA – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at Brookline Capital Management in a research report issued on Thursday, Benzinga reports. They currently have a $57.00 price target on the stock. Separately, HC Wainwright decreased their price target on shares of Edesa Biotech from $112.00 to […]